Note 3 - Selected Balance Sheet Data (Tables)

3 Months Ended

Sep. 30, 2021

Notes Tables

Schedule of Inventory, Current [Table Text Block]

	September 30,		June 30,
	2021		2021
Raw materials	$	58,001	$	55,096
Finished goods(1)		64,740		67,108
Inventories, net	$	122,741	$	122,204

Property, Plant and Equipment [Table Text Block]

	September 30,			June 30,
	2021			2021
Land	$	8,586		$	8,612
Buildings and improvements		191,284			190,661
Machinery and equipment		202,792			198,483
Property and equipment, cost		402,662			397,756
Accumulated depreciation and amortization		(195,528	)		(189,849	)
Property and equipment, net	$	207,134		$	207,907

Schedule of Intangible Assets and Goodwill [Table Text Block]

	September 30,			June 30,
	2021			2021
Developed technology	$	551,289		$	552,160
Trade names		147,245			147,640
Customer relationships		230,695			232,493
Patents		2,989			2,926
Other intangibles		6,309			6,316
Definite-lived intangible assets		938,527			941,535
Accumulated amortization		(364,927	)		(348,267	)
Definite-lived intangibles assets, net		573,600			593,268
In process research and development		22,700			22,700
Total intangible assets, net	$	596,300		$	615,968

Schedule of Finite-Lived Intangible Assets [Table Text Block]

Beginning balance	$	615,968
Acquisitions		-
Other additions		43
Amortization expense		(18,606	)
Currency translation		(1,105	)
Ending balance	$	596,300

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

2022 remainder	$	55,714
2023		72,454
2024		69,618
2025		66,372
2026		62,606
Thereafter		246,836
Total	$	573,600

Schedule of Goodwill [Table Text Block]

	Protein Sciences			Diagnostics and Genomics			Total
Beginning balance	$	392,717			450,350		$	843,067
Currency translation		(2,979	)		(68	)		(3,047	)
Ending balance	$	389,738		$	450,282		$	840,020